HCM - Company ID 0001648257
The table below shows HUTCHMED (China) Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $548.51M | $630.20M | $838.00M | $426.41M | $356.13M | $227.98M |
| Cost of revenue | $336.35M | $348.88M | $384.45M | $311.10M | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $148.29M | $212.11M | $302.00M | $386.89M | $299.09M | $174.78M |
HUTCHMED (China) Ltd reported annual revenue of $548.51M for fiscal year 2025. That is down 13.0% from $630.20M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $216.08M (FY 2016) to $548.51M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $66.72M |
| $64.30M |
| $79.78M |
| $92.17M |
| $89.30M |
| $50.02M |
| Operating income | -$39.16M | -$43.70M | $18.38M | -$407.69M | -$328.32M | -$196.67M |
| Income tax | $63.61M | $7.19M | $4.51M | -$283.00K | $11.92M | $4.83M |
| Net income | $456.91M | $37.73M | $100.78M | -$360.83M | -$194.65M | -$125.73M |
| EPS (diluted) | $0.52 | $0.04 | $0.12 | -$0.43 | -$0.25 | -$0.18 |